Baxter Healthcare Corporation recently launched the Education Advantage program, an innovative scholarship program to promote career development and encourage proactive health management and community involvement among people with hemophilia A. The program was developed with input from the bleeding disorders community. Teenagers and adults with hemophilia A, including those with inhibitors, are eligible for the program regardless of which brand of factor VIII product therapy they use. According to the Baxter press release, Education Advantage will be “tailored to the individual needs of patients.”

 

The Education Advantage program is supported by Baxter and independently managed by Scholarship America, a national, nonprofit scholarship program administrator. Scholarship America is solely responsible for reviewing all scholarship applications, determining eligibility and financial need, and selecting scholarship recipients. Once accepted, scholarship recipients will be required to actively participate in the program via ongoing community service and attending regular comprehensive health exams.

 

“The Education Advantage program is fulfilling a critical need in the hemophilia community through its unique combination of significant financial aid and resources that go beyond scholarships,” said Val Bias, NHF CEO. “By offering recipients access to tools that help them better manage various aspects of their life, the Education Advantage program helps them graduate as natural role models for other hemophilia patients. We commend Baxter for providing resources for hemophilia patients that help them excel not only in their careers, but also in their communities and beyond.”

 

For more information, go to: www.myeducationadvantage.com

 

Source: Baxter press release dated October 30, 2009